A Case Study on National List of Essential Medicines(NLEM)in India and WHO EML 2015-OverviewBandameedi R1*, Mohammed S2 and Soma H3
- Corresponding Author:
- Bandameedi R
K.V.K College of Pharmacy, Hyderabad, India
E-mail: [email protected]
Received: January 12, 2016; Accepted: January 27, 2016; Published: January 29, 2016
Citation: Bandameedi R, Mohammed S, Soma H (2016) A Case Study on National List of Essential Medicines (NLEM) in India and WHO EML 2015-Overview. Pharmaceut Reg Affairs 5:159. doi:10.4172/2167-7689.1000159
Copyright: © 2016 Bandameedi R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Availability of modern medicine increased all over the world due to huge expansion of the global Pharma market. At the same time misuse as well as accessibility of the most of essential drugs to majority of the population was denied due to cost-effectiveness of healthcare delivery combined with poor procurement policies and poor prescribing practices. During the recent years, the national list of India has assumed immense importance to improve access to medicines in India. It is therefore necessary to understand policies and guidelines followed in developing WHO essential drug list and national list of essential medicines. In this review article history of essential drug list and important inclusions in NLEM 2015 and WHO EML 2015 were highlighted.